INSIGHTS ON CLINICAL TRIAL DESIGN

• Challenges, Opportunities For Recruitment In The Digital Age

  Health literacy gaps and online misinformation hinder clinical trial recruitment. Meeting patients where they are — digitally and educationally — can improve engagement and enrollment success.

• Mergers And Acquisitions: How Institutional Knowledge Protecting Value

  M&A transitions can either preserve momentum or create costly setbacks. Learn how protecting institutional knowledge helps sponsors reduce risk, maintain continuity, and accelerate development.

• Human Abuse Potential: Participant Recruitment

  Take a look at the strategies behind successful human abuse potential studies, from volunteer recruitment models to retention challenges, and how participant experience directly impacts data quality.

• Implementing An ERP System: 5 Key Steps To A Successful Rollout

  Key success factors to implementing an ERP system include assembling a competent project team with leadership support, phased implementation to align with regulatory compliance, and careful data migration to ensure system reliability.

• A Novel Digital Measure For Tracking Disease Progression In DMD

  2/6/2026
• Ways To Avoid Rescue Trials From The Start

  5/12/2026

  What pushes a study into rescue mode? Explore the common causes of trial delays and how to address them before they impact timelines and outcomes.

• Partnership Driving Superior Enrollment And Speed In Phase III Trial

  1/31/2025

  Examine the partnership between CRIO and Sitero, including how it underscores the significant impact of technology in optimizing trial performance and accelerating treatment development.

• Applying AI to Study Simulation: From Design to Analysis

  5/12/2026

  See how AI-generated synthetic patient populations can mirror real trial outcomes, enabling teams to test assumptions, refine protocols, and anticipate variability early — helping reduce risk, cost, and time while improving study design decisions.

• The Phase 2 Endpoint Dilemma

  3/31/2026

  Phase 2 neuro endpoints can miss subtle change. Learn when composites help or hinder, how to align cognition, function, and biomarkers with real-world data for go/no-go decisions.